Frequency of anticancer drug use at the end of life : a scoping review
Szigethy, Endre (Epidy Kft (Ungria))
Dorantes, Rosario (Parc de Salut MAR de Barcelona)
Sugrañes, Miguel (Universitat Autònoma de Barcelona)
Madera, Meisser (University of Cartagena. Research Department, Faculty of Dentistry)
Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau)
Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau)
Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau)
Universitat Autònoma de Barcelona

Date:	2023
Abstract:	Anticancer drug use at the end of life places potential extra burdens on patients and the healthcare system. Previous articles show variability in methods and outcomes; thus, their results are not directly comparable. This scoping review describes the methods and extent of anticancer drug use at end of life. Systematic searches in Medline and Embase were conducted to identify articles reporting anticancer drug use at the end of life. We selected 341 eligible publications, identifying key study features including timing of research, disease status, treatment schedule, treatment type, and treatment characteristics. Among the subset of 69 articles of all cancer types published within the last 5 years, we examined the frequency of anticancer drug use across various end of life periods. This comprehensive description of publications on anticancer drug use at end of life underscores the importance of methodological factors when designing studies and comparing outcomes. The online version contains supplementary material available at 10. 1007/s12094-023-03234-1.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Neoplasms ; Anticancer agents ; Terminal care ; Medical overuse
Published in:	Clinical & translational oncology, june 2023, p. 1-12, ISSN 1699-3055

DOI: 10.1007/s12094-023-03234-1
PMID: 37286888

12 p, 1.0 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles